The Disease Clearing Potential of CAR T-Cell Therapy for Autoimmune Diseases

Karen Walker
Chief Technology Officer
Kyverna Therapeutics

In this fireside chat, Karen Walker, Chief Technology Officer at Kyverna Therapeutics, shares insights into the groundbreaking potential of CAR T-cell therapy to transform the treatment of autoimmune diseases. She explores emerging science, early clinical progress, and what this next frontier could mean for long-term disease remission and patient outcomes.